<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2313-8955-2017-3-1-8-14</article-id><article-id pub-id-type="publisher-id">993</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>RELATIONSHIP BETWEEN INSULIN-LIKE GROWTH FACTOR-1 AND INDICATORS OF THE CARBOHYDRATE METABOLISM IN PATIENTS WITH COMORBIDITY OF ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS</article-title><trans-title-group xml:lang="en"><trans-title>RELATIONSHIP BETWEEN INSULIN-LIKE GROWTH FACTOR-1 AND INDICATORS OF THE CARBOHYDRATE METABOLISM IN PATIENTS WITH COMORBIDITY OF ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Pyvovarov</surname><given-names>Alexander V.</given-names></name><name xml:lang="en"><surname>Pyvovarov</surname><given-names>Alexander V.</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="epub"><year>2017</year></pub-date><volume>3</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2017/1/Медицина_1-8-14.pdf" /><abstract xml:lang="ru"><p>Relevance. Insulin and insulin-like growth factor-1 are regarded as a single signal system that regulates the metabolism and processes of cell growth and differentiation. Despite the known mechanisms of the effect of insulin-like growth factor-1, there are still some unclear issues regarding somatomedin participation in the regulation of carbohydrate metabolism in patients with hypertension and in patients with concomitant hypertension and over with type 2 diabetes mellitus. Studying the role of insulin-like growth factor-1 in the pathogenesis of type 2 diabetes mellitus is an urgent problem that requires further investigation. Problem. The author studies the correlations between the level of insulin-like growth factor - 1 in the blood and indicators of the state of carbohydrate metabolism. Materials and methods. A total of 120 people, including 100 patients with cardiological and endocrinological problems, and 20 healthy subjects in the control group. The first group included 60 patients with hypertension, the second - 40 patients with combined pathology of hypertension and type 2 diabetes mellitus. The researches determined the level of blood sugar on an empty stomach, the level of insulin, glycosylated hemoglobin, insulin-like growth factor-1, and calculated the HOMA-IR index. Results. The highest average level of insulin-like growth factor-1 in blood was observed in patients with a concomitant course of hypertension and type 2 diabetes mellitus. All selected groups observed a direct correlation between the level of insulin-like growth factor-1 in the blood and the value of the HOMA-ІR index. The highest value of the correlation coefficient turned out to be in the second group of patients with a concomitant course of hypertension and type 2 diabetes mellitus. Conclusions. It was found that the detection of high levels of insulin-like growth factor-1 in the blood allows to set the risk of progression of disorders of the carbohydrate metabolism in hypertensive patients in the early stages, thereby increasing the effectiveness of an early diagnosis of type 2 diabetes mellitus.</p></abstract><trans-abstract xml:lang="en"><p>Relevance. Insulin and insulin-like growth factor-1 are regarded as a single signal system that regulates the metabolism and processes of cell growth and differentiation. Despite the known mechanisms of the effect of insulin-like growth factor-1, there are still some unclear issues regarding somatomedin participation in the regulation of carbohydrate metabolism in patients with hypertension and in patients with concomitant hypertension and over with type 2 diabetes mellitus. Studying the role of insulin-like growth factor-1 in the pathogenesis of type 2 diabetes mellitus is an urgent problem that requires further investigation. Problem. The author studies the correlations between the level of insulin-like growth factor - 1 in the blood and indicators of the state of carbohydrate metabolism. Materials and methods. A total of 120 people, including 100 patients with cardiological and endocrinological problems, and 20 healthy subjects in the control group. The first group included 60 patients with hypertension, the second - 40 patients with combined pathology of hypertension and type 2 diabetes mellitus. The researches determined the level of blood sugar on an empty stomach, the level of insulin, glycosylated hemoglobin, insulin-like growth factor-1, and calculated the HOMA-IR index. Results. The highest average level of insulin-like growth factor-1 in blood was observed in patients with a concomitant course of hypertension and type 2 diabetes mellitus. All selected groups observed a direct correlation between the level of insulin-like growth factor-1 in the blood and the value of the HOMA-ІR index. The highest value of the correlation coefficient turned out to be in the second group of patients with a concomitant course of hypertension and type 2 diabetes mellitus. Conclusions. It was found that the detection of high levels of insulin-like growth factor-1 in the blood allows to set the risk of progression of disorders of the carbohydrate metabolism in hypertensive patients in the early stages, thereby increasing the effectiveness of an early diagnosis of type 2 diabetes mellitus.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>insulin-like growth factor-1</kwd><kwd>arterial hypertension</kwd><kwd>diabetes mellitus type 2</kwd></kwd-group><kwd-group xml:lang="en"><kwd>insulin-like growth factor-1</kwd><kwd>arterial hypertension</kwd><kwd>diabetes mellitus type 2</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Altunina, N.V., Lizogub V.G.,&amp;nbsp; Pliskevich D.A.,&amp;nbsp; Bondarchuk A.M. Features of indicators of daily monitoring of arterial pressure in patients with essential hypertension combined with type 2 diabetes mellitus. Abstracts of scientific reports 2014. p.44.</mixed-citation></ref><ref id="B2"><mixed-citation>Hypertension unified clinical Protocol of primary, emergency and secondary specialized care. URL: http://www.mif-ua.com/archive/article/31084 (date of access: December 3, 2016).</mixed-citation></ref><ref id="B3"><mixed-citation>Zhuravleva L.V., Kovaleva O.N. Insulin-like growth factor and myocardial remodeling in patients with arterial hypertension. Ukrainian magazine of cardiology. 2006. N 5.&amp;nbsp; Pp. 32-37.</mixed-citation></ref><ref id="B4"><mixed-citation>Zhuravlyova, L.V., Pyvovarov O.V. Risk factors and prediction of the development of combined pathology of type 2 diabetes mellitus in hypertensive patients. Art treatment. 2014. № 9-10. Pp. 6-9.</mixed-citation></ref><ref id="B5"><mixed-citation>Kovaleva O.N. Prediabetes diagnostic criteria and clinical significance in cardiology. Health protection of Ukraine 2012. Pp. 24-25.</mixed-citation></ref><ref id="B6"><mixed-citation>Reznik L.A., Starchenko T.G., Scapa V.L., Gaidukov E.A. Insulin-like growth factor 1 and metabolic parameters in patients with essential hypertension in combination with type 2 diabetes and without it. Ukrainian medicine almanac. 2011. Vol. 14. N.5. Pp. 169-171.</mixed-citation></ref><ref id="B7"><mixed-citation>Diseases of the circulatory system as a medical-social and socio-political problem. Analytical-methodological manual recommended for cardiologists, rheumatologists, internists, and healthcare professionals and General practitioners / under the editorship of V. M. Kovalenko. M.: GU National Research Centre &amp;quot;Сardiology Institut named after Academician. M.D. Strazhesko&amp;quot;, 2014. 280 p.</mixed-citation></ref><ref id="B8"><mixed-citation>Aguirre G.&amp;nbsp;A.,&amp;nbsp;Rodr&amp;iacute;guez&amp;nbsp;De&amp;nbsp;Ita J., de la&amp;nbsp;Garza&amp;nbsp;R.&amp;nbsp;G.&amp;nbsp;and Castilla-Cortazar I.&amp;nbsp;Insulin-like growth factor-1 deficiency and metabolic syndrome. Journal of Translational Medicine. 2016.14. Pp. 3. DOI:&amp;nbsp;10.1186/s12967-015-0762-z.</mixed-citation></ref><ref id="B9"><mixed-citation>Ekstr&amp;ouml;m K., Salemyr J., Zachrisson I. et al. Normalization of the IGF &amp;ndash; IGFBP Axis by Sustained Nightly Insulinization in Type 1. Diabetes. Diabetes Care. 2007. Vol. 30. Pp.1357-1363.</mixed-citation></ref><ref id="B10"><mixed-citation>Matthias M. Weber M.M., Auernhammer C.J., Lee P.D.K. Insulin-Like Growth Factors and Insulin-Like Growth Factor Binding Proteins in Adult Patients with Severe Liver Disease before and after Orthotopic Liver Transplantation. Hormone Research. 2002. Vol. 57, № 3-4. Рp. 105-112.</mixed-citation></ref><ref id="B11"><mixed-citation>Min Sun Kim, MD&amp;nbsp;and&amp;nbsp;Dae-Yeol Lee, MD&amp;nbsp; Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus // Ann Pediatr Endocrinol Metab. 2015. 20(2). Pp. 69&amp;ndash;73.</mixed-citation></ref><ref id="B12"><mixed-citation>Protocol diabetes. URL: http://www.moz.gov.ua. (date of access: December 3, 2016).</mixed-citation></ref><ref id="B13"><mixed-citation>Razavian N.,&amp;nbsp;Blecker S.,&amp;nbsp;Schmidt A.M.,&amp;nbsp;Smith-McLallen A.,&amp;nbsp;S.,&amp;nbsp;Sontag D. Population-Level Prediction of&amp;nbsp; Type 2 Diabetes&amp;nbsp;From Claims Data and Analysis of&amp;nbsp; Risk&amp;nbsp; Factors. Big Data.&amp;nbsp;2015. 3(4). Pp 277-287.</mixed-citation></ref><ref id="B14"><mixed-citation>Rehman U. The role of growth hormone in the pathogenesis of vascular complications of diabetes mellitus. Am. J. Med. Sci. 2000. Vol. 320. Pp. 128-134.</mixed-citation></ref><ref id="B15"><mixed-citation>Sang Hui Chu, Ji Won Baek, Eun Sook Kim et al. Gender Diferences in Hypertension Control Among Older Korean Adults: Korean Social Life, Health, and Aging Project. J. Prev. Med. Public. Health. 2015.Vol. 48. Pp. 38-47.</mixed-citation></ref></ref-list></back></article>